Triple
T20061751
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | BEACOPP regimen |
E499491
|
entity |
| Predicate | componentDrug |
P82705
|
FINISHED |
| Object | procarbazine |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: procarbazine | Statement: [BEACOPP regimen, componentDrug, procarbazine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: procarbazine Context triple: [BEACOPP regimen, componentDrug, procarbazine]
-
A.
cyclophosphamide
Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
-
B.
Bicutan
Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
-
C.
mitoxantrone
Mitoxantrone is an anthracenedione chemotherapeutic agent used primarily to treat certain cancers and multiple sclerosis by intercalating DNA and inhibiting topoisomerase II.
-
D.
vincristine
Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
-
E.
irinotecan
Irinotecan is a chemotherapy drug, specifically a topoisomerase I inhibitor, commonly used to treat colorectal and other cancers.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: procarbazine Target entity description: Procarbazine is an oral alkylating chemotherapy agent primarily used in combination regimens to treat Hodgkin lymphoma and certain brain tumors.
-
A.
cyclophosphamide
Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
-
B.
Bicutan
Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
-
C.
mitoxantrone
Mitoxantrone is an anthracenedione chemotherapeutic agent used primarily to treat certain cancers and multiple sclerosis by intercalating DNA and inhibiting topoisomerase II.
-
D.
vincristine
Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
-
E.
irinotecan
Irinotecan is a chemotherapy drug, specifically a topoisomerase I inhibitor, commonly used to treat colorectal and other cancers.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69da6276bcf48190aabbf279192a5fb4 |
completed | April 11, 2026, 3:02 p.m. |
| NER | Named-entity recognition | batch_69e6637601dc8190a07fc20844093cb7 |
completed | April 20, 2026, 5:33 p.m. |
Created at: April 11, 2026, 3:38 p.m.